Literature DB >> 30083722

Implications of the New American College of Cardiology Guidelines for Hypertension Prevalence in India.

Nikhil Srinivasapura Venkateshmurthy1, Pascal Geldsetzer2, Lindsay M Jaacks2, Dorairaj Prabhakaran1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30083722      PMCID： PMC6233754          DOI： 10.1001/jamainternmed.2018.3511

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

2.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

3.  Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults.

Authors:  Pascal Geldsetzer; Jennifer Manne-Goehler; Michaela Theilmann; Justine I Davies; Ashish Awasthi; Sebastian Vollmer; Lindsay M Jaacks; Till Bärnighausen; Rifat Atun
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

Review 4.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

5.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

Review 6.  Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension.

Authors:  Raghupathy Anchala; Nanda K Kannuri; Hira Pant; Hassan Khan; Oscar H Franco; Emanuele Di Angelantonio; Dorairaj Prabhakaran
Journal:  J Hypertens       Date:  2014-06       Impact factor: 4.844
  6 in total
  8 in total

1.  Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.

Authors:  Yan-Feng Zhou; Na Liu; Pei Wang; Jae Jeong Yang; Xing-Yue Song; Xiong-Fei Pan; Xiaomin Zhang; Meian He; Honglan Li; Yu-Tang Gao; Yong-Bing Xiang; Tangchun Wu; Danxia Yu; An Pan
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

2.  Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.

Authors:  Aliza Hussain; Salim S Virani; Luke Zheng; Ty J Gluckman; William B Borden; Frederick A Masoudi; Thomas M Maddox
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

3.  Variation in the Proportion of Adults in Need of Blood Pressure-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1 037 215 Individuals From 50 Nationally Representative Surveys.

Authors:  Nikkil Sudharsanan; Michaela Theilmann; Tabea K Kirschbaum; Jennifer Manne-Goehler; Sina Azadnajafabad; Pascal Bovet; Simiao Chen; Albertino Damasceno; Jan-Walter De Neve; Maria Dorobantu; Cara Ebert; Farshad Farzadfar; Gladwell Gathecha; Mongal Singh Gurung; Kosar Jamshidi; Jutta M A Jørgensen; Demetre Labadarios; Julia Lemp; Nuno Lunet; Joseph K Mwangi; Sahar Saeedi Moghaddam; Silver K Bahendeka; Zhaxybay Zhumadilov; Till Bärnighausen; Sebastian Vollmer; Rifat Atun; Justine I Davies; Pascal Geldsetzer
Journal:  Circulation       Date:  2021-02-08       Impact factor: 29.690

4.  A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative.

Authors:  Ashish Krishna; Anupam K Pathni; Bhawna Sharma; Roopa Shivashankar; Suyesh Shrivastava; Dagmara Hering
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-20       Impact factor: 3.738

5.  Hypertension prevalence as a function of different guidelines, India.

Authors:  Manisha Dubey; Sanjay Rastogi; Ashish Awasthi
Journal:  Bull World Health Organ       Date:  2019-09-17       Impact factor: 9.408

6.  Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.

Authors:  Kartik Gupta; Sivasubramanian Ramakrishnan; Geevar Zachariah; J Shivkumar Rao; P P Mohanan; K Venugopal; Santosh Sateesh; Rishi Sethi; Dharmendra Jain; Neil Bardolei; Kalaivani Mani; Tanya Singh Kakar; Vardhmaan Jain; Prakash Gupta; Rajeev Gupta; Sandeep Bansal; Ranjit K Nath; Sanjay Tyagi; G S Wander; Satish Gupta; Subroto Mandal; Nagendra Boopathy Senguttuvan; Geetha Subramanyam; Debabatra Roy; Sibananda Datta; Kajal Ganguly; S N Routray; S S Mishra; B P Singh; B B Bharti; Mrinal Kanti Das; P K Deb; Prakash Deedwania; Ashok Seth
Journal:  Int J Cardiol Hypertens       Date:  2020-10-07

7.  Hypertension defined by the 2017 ACC/AHA guideline is more accurate than 2018 ESC/ESH for detecting early vascular aging in young adults.

Authors:  Mariana P de Souza; Paulo Cesar Lopes; Gabriel Bazo; Paulo Ricardo H Rocha; Daniela Aparecida Lorencini; Heloisa Bettiol; Marco Antonio Barbieri; Eduardo B Coelho
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

8.  Smart phone-based transcutaneous electrical acupoint stimulation as adjunctive therapy for hypertension (STAT-H trial): protocol for a cluster randomised controlled trial.

Authors:  Jian-Feng Tu; Si-Bo Kang; Li-Qiong Wang; Shi-Yan Yan; Chao-Qun Yan; Xin-Tong Su; Guang-Xia Shi; Bao-Hong Mi; Ying Lin; Yu Wang; He-Wen Li; Xue-Zhou Wang; Xiao Wang; Jing-Wen Yang; Cun-Zhi Liu
Journal:  BMJ Open       Date:  2022-07-28       Impact factor: 3.006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.